Progressive muscular dystrophy: Duchenne type. Controversies of the kinesitherapy treatment

Detalhes bibliográficos
Autor(a) principal: Leitão,Ana Valéria de Araujo
Data de Publicação: 1995
Outros Autores: Duro,Luiz Alves, Penque,Glória Maria Cardoso de Andrade
Tipo de documento: Artigo
Idioma: eng
Título da fonte: São Paulo medical journal (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31801995000500007
Resumo: The authors carried out a study of children with progressive muscular dystrophy of Duchenne type (DMD), giving special attention to physiatrical follow-up, having in mind that the practice of exercises has been debated very much in the specialized literature. The goal of this study is to try to settle the limits for the utilization of kinesitherapy which should be applied only in specific situations, such as: after skeletal muscular trauma or when the respiratory system is at risk. In this situation the physiatrical procedure would be to restrict physical activity, with early use of wheelchairs and the exclusion of the use of orthoses for orthostatism. DMD, at present, has been considered a result of duplication (60%), deletion (5 to 6%) or point mutations at gen Xp21 (Zatz, 1994), that codifies a protein called Dystrophin ( Hoffman et al., 1987). Dystrophin is a cytoskeletal sarcolemmic protein that constitutes about .002% of the total protein of the muscle, present in skeletal fibers concentrated in muscle tendinous joints, which supplies mechanical reinforcement to the surface of the membrane during stretching and shortening physical activity. This protein is absent in DMD cases, wherefore, the sarcolemma undergoes a segmentary necrosis losing its contractile property during eccentric and concentric physical activity. The importance of physiatrical follow-up for DMD patients is to avoid deformities and tendon shortening, to ameliorate the patient's quality of life, to provide respiratory assistance and general couseling to members of the patient's family. The objective of this study is to try to clarify the risks and possibilities of kinesitherapy applied to DMD cases.
id APM-1_6782e9351e452c5136e0d4f3a8f3c00b
oai_identifier_str oai:scielo:S1516-31801995000500007
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling Progressive muscular dystrophy: Duchenne type. Controversies of the kinesitherapy treatmentNeuromuscular diseaseDuchenne muscular dystrophyThe authors carried out a study of children with progressive muscular dystrophy of Duchenne type (DMD), giving special attention to physiatrical follow-up, having in mind that the practice of exercises has been debated very much in the specialized literature. The goal of this study is to try to settle the limits for the utilization of kinesitherapy which should be applied only in specific situations, such as: after skeletal muscular trauma or when the respiratory system is at risk. In this situation the physiatrical procedure would be to restrict physical activity, with early use of wheelchairs and the exclusion of the use of orthoses for orthostatism. DMD, at present, has been considered a result of duplication (60%), deletion (5 to 6%) or point mutations at gen Xp21 (Zatz, 1994), that codifies a protein called Dystrophin ( Hoffman et al., 1987). Dystrophin is a cytoskeletal sarcolemmic protein that constitutes about .002% of the total protein of the muscle, present in skeletal fibers concentrated in muscle tendinous joints, which supplies mechanical reinforcement to the surface of the membrane during stretching and shortening physical activity. This protein is absent in DMD cases, wherefore, the sarcolemma undergoes a segmentary necrosis losing its contractile property during eccentric and concentric physical activity. The importance of physiatrical follow-up for DMD patients is to avoid deformities and tendon shortening, to ameliorate the patient's quality of life, to provide respiratory assistance and general couseling to members of the patient's family. The objective of this study is to try to clarify the risks and possibilities of kinesitherapy applied to DMD cases.Associação Paulista de Medicina - APM1995-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31801995000500007Sao Paulo Medical Journal v.113 n.5 1995reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APM10.1590/S1516-31801995000500007info:eu-repo/semantics/openAccessLeitão,Ana Valéria de AraujoDuro,Luiz AlvesPenque,Glória Maria Cardoso de Andradeeng2009-01-15T00:00:00Zoai:scielo:S1516-31801995000500007Revistahttp://www.scielo.br/spmjhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2009-01-15T00:00São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv Progressive muscular dystrophy: Duchenne type. Controversies of the kinesitherapy treatment
title Progressive muscular dystrophy: Duchenne type. Controversies of the kinesitherapy treatment
spellingShingle Progressive muscular dystrophy: Duchenne type. Controversies of the kinesitherapy treatment
Leitão,Ana Valéria de Araujo
Neuromuscular disease
Duchenne muscular dystrophy
title_short Progressive muscular dystrophy: Duchenne type. Controversies of the kinesitherapy treatment
title_full Progressive muscular dystrophy: Duchenne type. Controversies of the kinesitherapy treatment
title_fullStr Progressive muscular dystrophy: Duchenne type. Controversies of the kinesitherapy treatment
title_full_unstemmed Progressive muscular dystrophy: Duchenne type. Controversies of the kinesitherapy treatment
title_sort Progressive muscular dystrophy: Duchenne type. Controversies of the kinesitherapy treatment
author Leitão,Ana Valéria de Araujo
author_facet Leitão,Ana Valéria de Araujo
Duro,Luiz Alves
Penque,Glória Maria Cardoso de Andrade
author_role author
author2 Duro,Luiz Alves
Penque,Glória Maria Cardoso de Andrade
author2_role author
author
dc.contributor.author.fl_str_mv Leitão,Ana Valéria de Araujo
Duro,Luiz Alves
Penque,Glória Maria Cardoso de Andrade
dc.subject.por.fl_str_mv Neuromuscular disease
Duchenne muscular dystrophy
topic Neuromuscular disease
Duchenne muscular dystrophy
description The authors carried out a study of children with progressive muscular dystrophy of Duchenne type (DMD), giving special attention to physiatrical follow-up, having in mind that the practice of exercises has been debated very much in the specialized literature. The goal of this study is to try to settle the limits for the utilization of kinesitherapy which should be applied only in specific situations, such as: after skeletal muscular trauma or when the respiratory system is at risk. In this situation the physiatrical procedure would be to restrict physical activity, with early use of wheelchairs and the exclusion of the use of orthoses for orthostatism. DMD, at present, has been considered a result of duplication (60%), deletion (5 to 6%) or point mutations at gen Xp21 (Zatz, 1994), that codifies a protein called Dystrophin ( Hoffman et al., 1987). Dystrophin is a cytoskeletal sarcolemmic protein that constitutes about .002% of the total protein of the muscle, present in skeletal fibers concentrated in muscle tendinous joints, which supplies mechanical reinforcement to the surface of the membrane during stretching and shortening physical activity. This protein is absent in DMD cases, wherefore, the sarcolemma undergoes a segmentary necrosis losing its contractile property during eccentric and concentric physical activity. The importance of physiatrical follow-up for DMD patients is to avoid deformities and tendon shortening, to ameliorate the patient's quality of life, to provide respiratory assistance and general couseling to members of the patient's family. The objective of this study is to try to clarify the risks and possibilities of kinesitherapy applied to DMD cases.
publishDate 1995
dc.date.none.fl_str_mv 1995-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31801995000500007
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31801995000500007
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1516-31801995000500007
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Paulista de Medicina - APM
publisher.none.fl_str_mv Associação Paulista de Medicina - APM
dc.source.none.fl_str_mv Sao Paulo Medical Journal v.113 n.5 1995
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1754209259237670913